Memantine Hydrochloride Capsule, Extended Release
NDC 70436-054
Product Information
Memantine Hydrochloride is a ANDA-approved product labeled by Slate Run Pharmaceuticals, Llc. This medication is typically used as a n-methyl-d-aspartate receptor antagonist [epc]. It is supplied as a yellow capsule, extended release for oral administration. This product entry covers the primary NDC 70436-054 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
YH;123
Code Structure Chart
Product Details
What is NDC 70436-054?
What are the uses of this product?
What are Active Ingredients of this product?
- MEMANTINE HYDROCHLORIDE 7 mg/1 - AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MEMANTINE HYDROCHLORIDE (UNII: JY0WD0UA60)
- MEMANTINE (UNII: W8O17SJF3T) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- AMMONIA (UNII: 5138Q19F1X)
- ETHYLCELLULOSE, UNSPECIFIED (UNII: 7Z8S9VYZ4B)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- GELATIN (UNII: 2G86QN327L)
- HYDROXYETHYL CELLULOSE, UNSPECIFIED (UNII: T4V6TWG28D)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
- OLEIC ACID (UNII: 2UMI9U37CP)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)
- POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)
- SHELLAC (UNII: 46N107B71O)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 996594 - memantine HCl 14 MG 24HR Extended Release Oral Capsule
- RxCUI: 996594 - 24 HR memantine hydrochloride 14 MG Extended Release Oral Capsule
- RxCUI: 996594 - memantine hydrochloride 14 MG 24 HR Extended Release Oral Capsule
- RxCUI: 996603 - memantine HCl 21 MG 24HR Extended Release Oral Capsule
- RxCUI: 996603 - 24 HR memantine hydrochloride 21 MG Extended Release Oral Capsule
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Memantine
Memantine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Memantine is in a class of medications called NMDA receptor antagonists. It works by decreasing abnormal activity in the brain. Memantine may improve the ability to think and remember or may slow the loss of these abilities in people who have AD. However, memantine will not cure AD or prevent the loss of these abilities at some time in the future.
[Learn More]
* Please review the full disclaimer at the bottom of this page.